CAI
Caris Life Sciences, Inc.
Caris Life Sciences, Inc. (CAI) has 9 SEC Form 4 filings (9 transaction rows) in the rolling window, disclosed by 2 distinct insiders. Most recent filing: Jul 13, 2026.
Insiders have net bought $1.5M over the trailing 6 months.
- Industry:Biotechnology
- CEO:David Dean Halbert
- Employees:1,769
- HQ:Irving, TX, US
- IPO:2025-06-18
Insider Buying
$1.5M
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Unique Insiders
2
in the rolling window
Market Cap
$4.4B
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
HALBERT JONFirst filing | Director | Purchase | 68,000 | $990K | Jul 13 | SEC ↗ |
Vacirca Jeff LFirst filing | Director | Purchase | 31,050 | $501K | May 12 | SEC ↗ |
Related companies
Caris Life Sciences, Inc. is in the Healthcare sector.